Status regarding Novo Nordisk's holding of its own shares (31 March 2016)
Bagsværd, Denmark, 01 April 2016 - In continuation of the company's announcements dated 29 October 2015 and 3 February 2016 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 31 March 2016 owned 58,672,645 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 11,734,529 or 2.3% of the total share capital.
In the first quarter of 2016 a total of 10,670,964 B shares were repurchased, and 4,167,022 B shares were disposed to employees in connection with employee incentive programmes.
Further information
Media: | ||
Anne Margrethe Hauge | +45 3079 3450 | amhg@novonordisk.com |
Investors: |
||
Peter Hugreffe Ankersen | +45 3075 9085 | phak@novonordisk.com |
Daniel Bohsen | +45 3079 6376 | dabo@novonordisk.com |
Melanie Raouzeos | +45 3075 3479 | mrz@novonordisk.com |
Kasper Veje | +45 3079 8519 | kpvj@novonordisk.com |
Company announcement No 26/2016
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire
HUG#1999814
\Hugin
Mest læste lige nu
Seneste nyheder
- 1 af 1188
- næste ›